Skip to main content

GSA Logo High Res No Background (1) (2)-1

 

DONATE NOW

    colleen

    February 28, 2025
    Articles By colleen

    Eight Years of Real-Life Experience with Smoothened Inhibitors in a Swiss Tertiary Skin Referral Center

    Posted by colleen, May 19, 2022
    Click here to view the article on PubMed.

    Illuminating Alternative Strategies to Treat Targeted Chemotherapy-Resistant Sporadic Basal Cell Carcinoma

    Posted by colleen, May 13, 2022
    Click HERE to view the article on PubMed.gov.

    Gorlin Syndrome: Assessing Genotype-Phenotype Correlations and Analysis of Early Clinical Characteristics as Risk Factors for Disease Severity

    Posted by colleen, Apr 02, 2022
    Click HERE to view the article in the Journal of Clinical Oncology.

    Beyond the Creams and Cutting Webinar

    Posted by colleen, Mar 13, 2022
    The GSA hosted our first webinar on Thursday, February 28th. Beyond the Creams and Cutting Webinar was highly attended and ...

    Specific temperament in patients with nevoid basal cell carcinoma syndrome

    Posted by colleen, Feb 22, 2022
    Click HERE to view the article on PubMed.

    Blood Donation and Gorlin Syndrome

    Posted by colleen, Feb 04, 2022
    The statements below are approved by GSA's Medical and Scientific Advisory Committee:

    Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial

    Posted by colleen, Feb 03, 2022
    Click HERE to view the article on PubMed.gov.

    The Gorlin Syndrome Alliance and NORD Launch Natural History Study for Gorlin Syndrome

    Posted by colleen, Nov 19, 2021
    Click HERE to read the NORD press release. Click HERE to view information on the Gorlin Syndrome Alliance Patient Registry ...

    Assessment of various efficacy outcomes using ERIVANCE-like criteria in patients with locally advanced basal cell carcinoma receiving sonidegib: results from a preplanned sensitivity analysis

    Posted by colleen, Nov 19, 2021
    Click here to read the article on the BMC Cancer website.

    Treatment of Advanced Basal Cell Carcinoma with Hedgehog Pathway Inhibitors: A Multidisciplinary Expert Meeting

    Posted by colleen, Nov 15, 2021
    Click here to view the article on PubMed.

    GSA Logo High Res No Background (1) (2)

    Contact Us

    Email: info@gorlinsyndrome.org

    Address: 

    3005 S. Lamar Blvd D109 #264

    Austin, TX 78704

    Phone: 267-689-6443

     

    Join the GSA Community to find support, empowerment and hope. You are not alone.
     
    Our mission: to thoughtfully support, comprehensively educate, and aggressively seek the best treatments and a cure for those affected by Gorlin syndrome.